Addiction Medicine
From the Journals
Medications for opioid addiction significantly underutilized
“More than 80,000 people are dying of a drug overdose involving an opioid every year, while safe and effective medicines to treat opioid use...
From the Journals
OxyContin marketing push still exacting a deadly toll, study says
The authors say their findings support the view that the opioid epidemic is creating a converging public health crisis, as it is fueling a surge...
Commentary
A new and completely different pain medicine
Patients assigned to the highest dose of VX-548 had a statistically significant lower cumulative amount of pain in the 48 hours after surgery.
Latest News
Nonalcohol substance use disorder tied to bariatric surgery
Only gastric bypass was associated with an increased incidence of nonalcoholic substance use disorder.
From the Journals
Women increasingly dying of alcohol-related causes
“There are risks of alcohol that are unique to women for a variety of reasons, including differences in metabolism and the impact of hormones, as...
Latest News
Most Americans in favor of regulated therapeutic psychedelics
When asked who should be eligible for treatment with psychedelics, 80% said that they were comfortable with its use for those with terminal...
Commentary
‘Body size is not a choice’ and deserves legal protections
Weight-based discrimination in the United States has increased by an estimated 66% over the past decade, putting it on par with the prevalence of...
News
Medical cannabis does not reduce use of prescription meds
“This study did not identify important effects of medical cannabis laws on receipt of opioid or nonopioid pain treatment among patients with...
Latest News
‘Landmark’ trial shows opioids for back, neck pain no better than placebo
Opioids don’t relieve low back or neck pain in the short term and lead to worse outcomes in the long term.
Latest News
New international guidelines on opioid deprescribing
The recommendations describe best practices for stopping opioid therapy and emphasize slow tapering and individualized deprescribing plans...
Commentary
New DEA CME mandate affects 2 million prescribers
One should not underestimate the sweeping scope of this new federal requirement.